Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment

出版年份 2017 全文链接

标题

作者

关键词

SLC22A3, cancer therapy, cisplatin, survival, head and neck squamous cell carcinoma

出版物

Volume 8, Issue 43, Pages -

出版商

Impact Journals, LLC

发表日期

2017-09-05

DOI

10.18632/oncotarget.20637

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now